Association Between Uric Acid and Acute Coronary Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-22

Study Completion Date

2024-03-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to acess the association between admission serum uric acid level and in\_hospital outcomes in patients with acute coronary syndromes

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Relationship Among, Serum Uric Acid, Left Ventricular Hypertrophy and Metabolic Syndrome

NCT03473951

Hyperuricemia Healthy

UNKNOWN

Screening and Management of Hyperuricemia in Patients with Chronic Medical Diseases in Assiut University Hospital

NCT06586229

Hyperuricemia

NOT_YET_RECRUITING

A Prospective Cohort Study of China Serum Uric Acid Levels

NCT03616769

Uric Acid Serum

COMPLETED

The Relationship Between Uric Acid and Inflammatory Markers

NCT01323335

Healthy Volunteers

COMPLETED PHASE1

Uric Acid Study in Healthy Male Volunteers

NCT00738842

Gout Coronary Artery Disease

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prospective study

1. To acess patients with acute coronary syndrome including one of (typical Chest pain \_ECGchanges \_elevated cardic enzyme)
2. the complication occur in patients with hyperurecemia and those with normal uric acid

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with normal uric acid levels

Patient with uric acid level (2.5\_6)for femal and (3\_7)for males

Uric acid level

Intervention Type DIAGNOSTIC_TEST

Uric acid will be measured for all Patients with acute coronary syndrome and result will be analysed

Patients with elevated uric acid level (hyperurecemia)

Uric acid level more than 7 for males and more than 6 for female

Uric acid level

Intervention Type DIAGNOSTIC_TEST

Uric acid will be measured for all Patients with acute coronary syndrome and result will be analysed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Uric acid level

Uric acid will be measured for all Patients with acute coronary syndrome and result will be analysed

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

all patients with acute coronary syndrome with one of the Following

* Typical Chest pain
* ECG changes
* Elevated cardiac enzyme

Exclusion Criteria

* patients aged less than 18 years
* patients with gout
* patients with treated with diuretics
* Patient with CKD
* Patient with chronic haemolytic anemia

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes